Description
TriTren 225 is the higher-concentration variant of the classical three-ester Trenbolone mix with 225mg Trenbolone per ml. The split typically follows the scheme 75/75/75mg per ester (Acetate, Enanthate, Hex), but can vary slightly by manufacturer.
Per study reports pharmacology corresponds exactly to TrenMix 200, only with somewhat higher dose per volume unit. This is relevant for research protocols with high Tren doses where required injection volume would otherwise hit practical limits.
The three esters together cover a broad half-life spectrum: Acetate ~3 days, Hex ~5-7 days, Enanthate ~7-10 days. The result is a smooth plasma level profile at two weekly injections.
As with all Trenbolone compounds: high androgen receptor affinity, no aromatization, progestagenic residual action. The typical Tren effects (night sweats, aggression, sleep disturbances, prolactin elevation with potential galactorrhea research findings, unfavorable lipid profile, tachycardia) tend to be more pronounced under TriTren due to higher dose than under TrenMix 200.
Trenbolone is on the WADA banned list.
You can order TriTren 225 as an oily injection solution in 10-pack at 225mg/ml.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
TriTren 225 is the higher-dose variant of the three-ester Tren mix - the effects described in the literature are identical to pure Trenbolone, but tend to be more pronounced than under TrenMix 200 due to the higher dose.
Documented in studies and the application literature:
- Progestagenic and prolactinergic action: Trenbolone acts progestagenically and drives prolactin levels up. Prolactin-mediated effects up to galactorrhea research findings are documented. Trenbolone does not aromatize.
- Suppression of endogenous production: Trenbolone strongly suppresses endogenous testosterone production. Testicular atrophy and reduced fertility are documented, a separate test base is mandatory in research practice.
- Tren-typical effects: user reports describe night sweats, sleep disturbances, aggression and tachycardia, tending to be more pronounced at the higher dose.
- Cardiovascular and liver: the literature describes an unfavorable lipid profile, and tight lipid monitoring becomes all the more important at the higher doses. Cardiac effects are documented in preclinical models, hepatotoxicity is not negligible.
Baseline bloodwork before, during and after a research protocol is strongly advised. This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- 17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate - American Journal of Physiology-Endocrinology and Metabolism 2011, Yarrow et al: central preclinical study on tissue-selective anabolic action of trenbolone without aromatization.
- Characterisation of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor - APMIS 2000, Bauer et al: quantitative binding data for 17β-trenbolone at the androgen receptor and progestin receptor - relevant to understanding the prolactin elevation under high Tren doses.
- Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome - Endocrinology 2016, Donner et al: preclinical data on cardiometabolic effects and ischemia-reperfusion tolerance under trenbolone treatment.
- Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids - International Journal of Drug Policy 2024, Piatkowski et al: cross-sectional study of 282 users with a dose-dependent association between trenbolone dose and verbal aggression - especially relevant at TriTren-typical higher doses.
- ‘I go back to it every f**king time’: the normalization of problematic Trenbolone use in online anabolic-androgenic steroid communities - Addiction Research and Theory 2024, Lamb et al: analysis of online communities documenting problematic use patterns and risk-taking among trenbolone users.
